骨折促进骨形成和骨缺陷修复通过ZBP1-STAT1-PKR-MLKL介导的亡
Suya Zhang1,2, Yudong Liu2, Zhaochen Ma2
1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, 12 Airport Road, Baiyun District, Guangzhou, 510405, China.
Chinese medicine
|January 18, 2024
概括
骨促进骨缺陷的修复,通过加速骨形成和抑制亡. 这项研究通过分子途径分析阐明了其治疗机制.
科学领域:
- 整形外科和再生医学
- 分子生物学和药理学 分子生物学和药理学
背景情况:
- 骨折证明了骨折治疗中的临床疗效.
- 其精确的治疗机制和分子点在很大程度上是未知的.
研究的目的:
- 调查骨缺陷修复中骨切割的药理作用和潜在机制.
- 为了确定由Osteoking调节的关键分子标和途径.
主要方法:
- 建立了一种老鼠骨缺陷模型,用于使用X射线,微型CT和组织病理学进行药理评估.
- 采用转录组分析来识别与骨缺陷相关的基因和骨质化的标.
- 构建了一个基因药物相互作用网络,以选和实验验证关键目标.
主要成果:
- 在老鼠中,骨显著加速皮质骨的修复和椎骨的生长.
- 在组织病理学和逆转异常的骨周转标记物中观察到剂量依赖的改善.
- 转录组分析涉及ZBP1-STAT1-PKR-MLKL通路;骨治疗逆转了ZBP1,STAT1,PKR和炎症细胞因子的升高,同时抑制了RIPK1/RIPK3/MLKL活动.
结论:
- 骨折促进骨的形成和缺陷的修复.
- 药物似乎通过调节ZBP1-STAT1-PKR轴来起作用,从而抑制RIPK1/RIPK3/MLKL介导的亡.
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


